Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Defining and conceptualising the commercial determinants of health
Anna Gilmore, Alice Fabbri, Fran Baum, et al.
The Lancet (2023) Vol. 401, Iss. 10383, pp. 1194-1213
Open Access | Times Cited: 335

Showing 1-25 of 335 citing articles:

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Michael Bräuer, Gregory A. Roth, Aleksandr Y. Aravkin, et al.
The Lancet (2024) Vol. 403, Iss. 10440, pp. 2162-2203
Open Access | Times Cited: 639
Commercial determinants of health: future directions
Sharon Friel, Jeff Collin, Mike Daube, et al.
The Lancet (2023) Vol. 401, Iss. 10383, pp. 1229-1240
Open Access | Times Cited: 101
Ultra-processed foods and cardiometabolic health: public health policies to reduce consumption cannot wait
Mathilde Touvier, Maria Laura da Costa Louzada, Dariush Mozaffarian, et al.
BMJ (2023), pp. e075294-e075294
Open Access | Times Cited: 77
Food Is Medicine: A Presidential Advisory From the American Heart Association
Kevin G. Volpp, Seth A. Berkowitz, Shreela V. Sharma, et al.
Circulation (2023) Vol. 148, Iss. 18, pp. 1417-1439
Open Access | Times Cited: 76
A global research priority agenda to advance public health responses to fatty liver disease
Jeffrey V. Lazarus, Henry E. Mark, Alina M. Allen, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 618-634
Open Access | Times Cited: 69
Conceptualising commercial entities in public health: beyond unhealthy commodities and transnational corporations
Jennifer Lacy‐Nichols, Sulakshana Nandi, Mélissa Mialon, et al.
The Lancet (2023) Vol. 401, Iss. 10383, pp. 1214-1228
Open Access | Times Cited: 62
The burden and trend of diseases and their risk factors in Australia, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Sheikh Mohammed Shariful Islam, Ralph Maddison, Riaz Uddin, et al.
The Lancet Public Health (2023) Vol. 8, Iss. 8, pp. e585-e599
Open Access | Times Cited: 48
Corporate Political Activity: Taxonomies and Model of Corporate Influence on Public Policy
Selda Ulucanlar, Kathrin Lauber, Alice Fabbri, et al.
International Journal of Health Policy and Management (2023) Vol. 12, pp. 7292-7292
Open Access | Times Cited: 47
Keeping It Political and Powerful: Defining the Structural Determinants of Health
Jonathan Heller, Marjory L. Givens, Sheri P. Johnson, et al.
Milbank Quarterly (2024) Vol. 102, Iss. 2, pp. 351-366
Open Access | Times Cited: 24
Opportunities and challenges following approval of resmetirom for MASH liver disease
Jeffrey V. Lazarus, Dana Ivancovsky‐Wajcman, Henry E. Mark, et al.
Nature Medicine (2024) Vol. 30, Iss. 12, pp. 3402-3405
Closed Access | Times Cited: 24
Western diets and chronic diseases
Timon E. Adolph, Herbert Tilg
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2133-2147
Closed Access | Times Cited: 19
Children, young people and the Commercial Determinants of Health
Hannah Pitt, Simone McCarthy, Grace Arnot
Health Promotion International (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 17
The Lancet Public Health Commission on gambling
Heather Wardle, Louisa Degenhardt, Virve Marionneau, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 11, pp. e950-e994
Open Access | Times Cited: 17
Socio‐economic association of alcohol use disorder and cardiovascular and alcohol‐associated liver disease from 2010 to 2019
Pojsakorn Danpanichkul, Vincent Chen, Nathorn Chaiyakunapruk, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 3, pp. 340-349
Closed Access | Times Cited: 16
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
Marie Ng, Emmanuela Gakidou, Justin Lo, et al.
The Lancet (2025) Vol. 405, Iss. 10481, pp. 813-838
Open Access | Times Cited: 7
Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021
Nicholas Steel, Clarissa Bauer‐Staeb, John Ford, et al.
The Lancet Public Health (2025)
Open Access | Times Cited: 5
The youth mental health crisis: analysis and solutions
Patrick D. McGorry, Hasini Gunasiri, Cristina Mei, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access | Times Cited: 4
A scoping review and expert consensus on digital determinants of health
Robin van Kessel, Laure-Elise Seghers, Michael Anderson, et al.
Bulletin of the World Health Organization (2025) Vol. 103, Iss. 02, pp. 110-125H
Open Access | Times Cited: 4
Regulatory responses to ultra-processed foods are skewed towards behaviour change and not food system transformation
Tanita Northcott, Mark Lawrence, Christine Parker, et al.
Nature Food (2025)
Closed Access | Times Cited: 3
A global action agenda for turning the tide on fatty liver disease
Jeffrey V. Lazarus, Henry E. Mark, Alina M. Allen, et al.
Hepatology (2023) Vol. 79, Iss. 2, pp. 502-523
Open Access | Times Cited: 33
Women and the commercial determinants of health
Simone McCarthy, Hannah Pitt, Marita Hennessy, et al.
Health Promotion International (2023) Vol. 38, Iss. 4
Open Access | Times Cited: 28
Public health approaches to gambling: a global review of legislative trends
Daria Ukhova, Virve Marionneau, Janne Nikkinen, et al.
The Lancet Public Health (2023) Vol. 9, Iss. 1, pp. e57-e67
Open Access | Times Cited: 27
Corporate interest groups and their implications for global food governance: mapping and analysing the global corporate influence network of the transnational ultra-processed food industry
Scott Slater, Mark Lawrence, Benjamin Wood, et al.
Globalization and Health (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Lung Disease and Social Justice: Chronic Obstructive Pulmonary Disease as a Manifestation of Structural Violence
Parris Williams, Sara Buttery, Anthony A Laverty, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 209, Iss. 8, pp. 938-946
Open Access | Times Cited: 13
Envisioning how to advance the MASH field
Alina M. Allen, Zobair M. Younossi, Anna Mae Diehl, et al.
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top